These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9723241)

  • 1. Population pharmacokinetics of cyclosporine: influence of covariables and assessment of cyclosporine absorption in kidney, lung, heart and heart + lung transplanted patients.
    Kyhl LE; Rasmussen SN; Aarons L; Jensen SB
    Transplant Proc; 1998 Aug; 30(5):1680. PubMed ID: 9723241
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical impact of Neoral in thoracic organ transplantation.
    Aziz T; el-Gamel A; Keevil B; Krysiak P; Campbell C; Rahman A; Deiraniya A; Yonan N
    Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.
    Mikhail G; Eadon H; Leaver N; Rogers P; Stephens D; Banner N; Khaghani A; Yacoub M
    Transplant Proc; 1997; 29(1-2):599-601. PubMed ID: 9123148
    [No Abstract]   [Full Text] [Related]  

  • 6. The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
    Wilczek HE; Berglin E; Blohmé I; Bäckman L; Fehrman I; Källen R; Nyberg G; Säwe J; Wahlberg J
    Transplant Proc; 1997; 29(1-2):280-3. PubMed ID: 9122995
    [No Abstract]   [Full Text] [Related]  

  • 7. Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial.
    Gullestad L; Mortensen SA; Eiskjær H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Iversen M
    Transplantation; 2010 Dec; 90(12):1581-9. PubMed ID: 21030905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoral conversion in stable thoracic transplant patients leads to dose reduction.
    Zaldonis DB; Keenan RJ; Pham SM; Kormos RL; Griffith BP
    Transplant Proc; 1998 Jun; 30(4):1158-9. PubMed ID: 9636468
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoral conversion in stable thoracic transplant patients leads to dose reduction.
    Zaldonis DB; Keenan RJ; Pham SM; Kormos RL; Griffith BP
    Transplant Proc; 1998 Aug; 30(5):1898-9. PubMed ID: 9723325
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term safety and efficacy of Neoral in heart transplantation.
    Yonan NA; Aziz T; el-Gamel A; Campbell CS; Rahman AN; Deiraniya AK
    Transplant Proc; 1998 Aug; 30(5):1906-9. PubMed ID: 9723328
    [No Abstract]   [Full Text] [Related]  

  • 12. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.
    Walker S; Habib S; Rose M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1519-20. PubMed ID: 9636618
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from standard cyclosporine to Neoral in lung transplant recipients.
    Kesten S; Scavuzzo M; Laurin L; Tan A; Chaparro C
    Transplant Proc; 1998 Aug; 30(5):1895-7. PubMed ID: 9723324
    [No Abstract]   [Full Text] [Related]  

  • 15. Case study: de novo application of Neoral in renal transplantation.
    Kahan BD
    Transplant Proc; 1996 Aug; 28(4):2189-91; discussion 2192, 2195. PubMed ID: 8769196
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal metabolism of cyclosporine A in human heart transplant recipients.
    Lehle K; Kirchner G; Sewing KF; Rupprecht L; Merk J; Preuner JG
    Transplant Proc; 1998 Dec; 30(8):4044. PubMed ID: 9865289
    [No Abstract]   [Full Text] [Related]  

  • 17. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
    Girault D; Haloun A; Viard L; Bellon G; Gottrand F; Guillemain R; Lenoir G; Ladurie FL; Plouvier E; Storni V
    Transplant Proc; 1995 Aug; 27(4):2488-90. PubMed ID: 7652899
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine pharmacology.
    Lee JI; Canafax DM
    Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral.
    Warrens AN; Salama A; Waters JB; Lechler RI
    Transplant Proc; 1996 Aug; 28(4):2169-70. PubMed ID: 8769190
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A; Pinto VM; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.